South Korean company Classys has acquired a majority stake in its Latin American distributor, marking a direct entry into the region's medical aesthetics market.
Classys, a South Korean company specializing in medical aesthetics technology, has made a significant move by acquiring 77.5% of JL Health, a Brazilian company that controls the MedSystems and BeautySystems brands, which have over 15,000 associated clinics across Latin America, including Argentina and Colombia. The acquisition was finalized for $11.7 million and included a buyout agreement for the remaining 22.5% of JL Health. This deal marks a strategic shift for Classys, allowing it to move away from operating solely through distributors and establish a direct presence in a growing market.
The purchase underscores Classys’s commitment to expanding its influence in the Latin American medical aesthetics sector. By directly operating within the region, Classys aims to enhance its service delivery and customer engagement, which they believe is critical in a competitive market that is rapidly evolving with new technologies and products. This acquisition not only boosts Classys’s operational capacity but also positions it to leverage JL Health’s extensive network of clinics to further penetrate the market.
As Classys begins this new chapter, the implications of this acquisition will likely resonate throughout the medical aesthetics industry in Latin America. With an increased focus on innovation and direct consumer engagement, Classys is set to compete more effectively against established local players and potentially influence trends in aesthetic treatments and technologies. This business strategy could pave the way for future expansions and collaborations within the region, as Classys solidifies its foothold in a market that promises substantial growth opportunities.
